Paste #F0WeRV-LS

Paste #iF8KcRcbT

Oxford-AstraZeneca CoviShield COVID-19 Vaccine

Vaxzevria, the COVID-19 vaccine developed by the University of Oxford and AstraZeneca, may cause some of the mostly mild-to-moderate side effects that people often encounter after any vaccination. However, there are also some recent controversies surrounding rare blood clotting incidents linked to this vaccine.All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub and follow our live updates page for the most recent information on the COVID-19 pandemic.The Oxford-AstraZeneca COVID-19 vaccine — also known as Vaxzevria, as of March 25, 2021 — is a two-dose vaccine jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.Serum Institute of India’s COVID-19 vaccine, called Covishield, is a version of the Oxford-AstraZeneca vaccine that manufacturers in India produce locally.According to AstraZeneca’s primary analysis of phase 3 trial data, the vaccine has a 76% efficacy rate after both doses.
Common side effects :







Smilz CBD Gummies